| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |